Abogen has been invited to the inaugural RNA-Based Therapeutics & Vaccines Summit Asia, taking place from November 18–20 in Incheon, South Korea.

Dr. Bo Ying, Founder, Chairman and CEO of Abogen, will join global pharmaceutical and biotech leaders to explore the latest advancements driving RNA technologies from research to commercialization. As a Scientific Advisory Committee member and invited speaker, he will share insights on our proprietary mRNA+LNP platform, the clinical progress of our mRNA cancer vaccine, and the development of mRNA-based T cell engagers.

Abogen's Speaking Session

Topic: Unlocking Recent Clinical Progress of mRNA-Based Vaccines & B-Cell Depletion Therapies

Date & Time: November 19, 9:00 AM (UTC+9)

Highlight：
①  Demonstrating Abogen’s unique mRNA and LNP platform
②  Sharing clinical data and progress of mRNA cancer vaccines
③  Accelerating preclinical and clinical development of mRNA-based T-cell engagers